Table 4. Rat serum chemistry summary.
Parameter | Control | Anti-Her2 position 1-ADC | Anti-Her2 position 1- ADC | Anti-Her2 position 1- ADC | Anti-Her2 Cys-ADC | Anti-Her2 Cys-ADC | Anti-Her2 Cys-ADC |
30 mg/kg | 60 mg/kg | 90 mg/kg | 30 mg/kg | 45 mg/kg | 60 mg/kg | ||
ALT | 33±3 | 51±8 | 122±88 | 112±27 | 178±98 | 180±124 | 345±365 |
AST | 108±28 | 223±38 | 697±770 | 619±294 | 848±351 | 732±381 | 2419±2853 |
Alkaline phosphatase | 150±28 | 196±53 | 612±680 | 573±318 | 329±72 | 541±183 | 898±412 |
GGT | 2±0 | 3±1 | 26±41 | 36±27 | 7±6 | 19±14 | 50±29 |
BUN | 15±1 | 21±2 | 22±13 | 19±3 | 22±3 | 21±8 | 42±15 |
Globulin | 2.3±0.1 | 3.0±0.2 | 3.6±0.5 | 3.9±0.4 | 3.8±0.4 | 3.6±0.2 | 3.2±0.4 |
Albumin | 3.1±0.1 | 3.0±0.1 | 2.7±0.2 | 2.6±0.2 | 2.8±0.3 | 2.3±0.2 | 2.0±0.3 |
A/G | 1.3±0.1 | 1.0±0.1 | 0.8±0.2 | 0.7±0.1 | 0.8±0.1 | 0.7±0.1 | 0.6±0.1 |
Triglycerides | 53±14 | 52±14 | 92±41 | 216±69 | 61±16 | 190±186 | 195±57 |
Comparison of selected serum chemistry parameters (Day 15) between cysteine and site specifically conjugated Her2 ADCs. A panel of serum markers was evaluated post single dose, i.v. administration of 30 or 60 mg/kg or 90 mg/kg of the anti-Her2 Cys or 30, 45 or 60 mg/kg anti-Her2 position 1-ADC.